In the December 2020 issue of The CRISPR Journal (vol. 3 no. 6; 440–453) the article entitled Evaluation of Homology-Independent CRISPR-Cas9 Off-Target Assessment Methods by Chaudhari et al. requires a correction.
The corresponding author has changed from
Andrew Kernytsky, PhD, CRISPR Therapeutics, Inc., 610 Main St., Cambridge, Massachusetts 02139, USA, Email; andrew.kernytsky@crisprtx.com
To
Hemangi Chaudhari, CRISPR Therapeutics, Inc., 610 Main St., Cambridge, Massachusetts 02139, USA, Email; hemangi.chaudhari@crisprtx.com
The online version of the article has been corrected.